Melanoma and Other Skin Cancers

7 protocols meet the specified criteria.
  • 20324

    ON-TRK: PrOspective Non-Interventional Study in Patients with Locally Advanced or Metastatic TRK Fusion Cancer Treated with Larotrectinib
  • A151804

    Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
  • EAY191

    Molecular Analysis for Combination Therapy Choice (ComboMATCH)
  • EAY191-A3

    A ComboMATCH Treatment Trial: Palbociclib and Binimetinib in RAS-Mutant Cancer
  • MK3475-630-07

    A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma
  • S2013

    Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study
  • WVU011118

    Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry